Mayo Clinic Launches New Diet Program

Designed by a Team of Mayo Clinic Dieticians and Medical Experts, the New Mayo Clinic Diet Draws on Unparalleled Expertise to Transform Lives

Mayo Clinic: The New Mayo Clinic Diet, the official diet developed by the Mayo Clinic, has launched nationwide. Through a medically-supported, scientifically rigorous and proven approach, The New Mayo Clinic Diet helps people lose weight to improve their health.

Built by a team of weight-loss experts at the Mayo Clinic, the program is built on a powerful new digital behavior change platform. The New Mayo Clinic Diet is designed to help members reshape their lifestyle by adopting healthy new habits and breaking unhealthy old ones.

The program includes Mayo Clinic-approved meal plans and recipes, based on a weight loss solution that consistently ranks on the US News & World Report Best Diet list and #1 on The New York Times bestseller list.

Members can choose from flexible meal plans, vegetarian, Mediterranean, high protein, and a new healthy keto program.

“The New Mayo Clinic Diet partners a whole-health weight loss program with an innovative digital platform.” said Donald D. Hensrud, MD, MS, Medical Director of the Mayo Clinic Healthy Living Program.”

The New Mayo Clinic Diet is built on an all-new digital platform from Digital Wellness, which has tools and trackers to help members lose 3x more weight. Exclusive tools such as a Habit Optimizer help members make lasting meaningful changes to their behavior. The program also includes unlimited access to a private Facebook Group that helps members connect and support each other.

The New Mayo Clinic Diet features:

  • Personalized Mayo Clinic-approved meal plans and recipes, based on the #1 New York Times best-selling diet that consistently ranks as a US News & World Report Best Diet
  • Holistic and whole self-focused program – Calorie counting not required
  • Food tracker with 1,000,000+ database
  • Equipment-free workouts
  • Tools to track progress and log your meals, exercise, measurements, and body weight
  • Access to the unparalleled educational content and expertise of the Mayo Clinic.
  • Mayo Clinic Diet 12-Week Course to help you learn the principles of healthy weight loss

“Another evolutionary element of the new Mayo Diet is a focus on the psychological aspects of weight management,” said Hensrud. “The new Mayo Clinic Diet Assessment assesses a participant’s diet mindset and gives them positive reassurance and mental support as they undertake a lifestyle change that, for many, can be very, very challenging.”

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.